Case number 1:21-cv-01783
Novo Nordisk Inc. et al v. Hikma Pharmaceuticals USA Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 17, 2023 | 52 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,579,869 B2; 7,762,994 B2; 8,114,833 B2; 9,265,893 B2. (Attachments: # 1 Stipulation and Order of Dismissal)(kmd) (Entered: 01/17/2023) (Stipulation and Order of Dismissal) (2) |
| Jan 17, 2023 | 52 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,579,869 B2; 7,762,994 B2; 8,114,833 B2; 9,265,893 B2. (Attachments: # 1 Stipulation and Order of Dismissal)(kmd) (Entered: 01/17/2023) (Main Document) (1) |
| Jan 17, 2023 | 51 | SO ORDERED, re 50 Stipulation of Dismissal, filed by Novo Nordisk A/S, Novo Nordisk Inc. CASE CLOSED. Signed by Judge Colm F. Connolly on 1/17/2023. (kmd) (Entered: 01/17/2023) (2) |
| Jan 13, 2023 | 50 | STIPULATION of Dismissal by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 01/13/2023) (2) |
| Dec 22, 2022 | 49 | SO ORDERED, re 48 Stipulation to Extend Certain Discovery Deadlines, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 12/22/2022. (kmd) (Entered: 12/22/2022) (3) |
| Dec 22, 2022 | 48 | STIPULATION and [Proposed] Order to Extend Certain Discovery Deadlines by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 12/22/2022) (3) |
| Dec 20, 2022 | 47 | NOTICE OF SERVICE of First Set of Requests for the Production of Documents and Things (Nos. 1-90) filed by Hikma Pharmaceuticals USA Inc..(Lennon, James) (Entered: 12/20/2022) (2) |
| Nov 9, 2022 | 43 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex. A - '833 Patent, # 2 Ex. B - '893 Patent)(Murray, Travis) (Entered: 11/09/2022) (Ex. B - '893 Patent) (9) |
| Nov 9, 2022 | 43 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex. A - '833 Patent, # 2 Ex. B - '893 Patent)(Murray, Travis) (Entered: 11/09/2022) (Ex. A - '833 Patent) (23) |
| Nov 9, 2022 | 46 | SO ORDERED, re 44 STIPULATION and Order Regarding Claim Construction, ORDER,terminating Deadlines and Hearings: Joint Claim Construction Brief Deadline terminated. Claim Construction Hearing (previously scheduled for 2/7/2023) terminated. Signed by Judge Colm F. Connolly on 11/9/2022. (nmf) (Entered: 11/09/2022) (4) |
| Nov 9, 2022 | 45 | MOTION for Claim Construction re 43 Claim Construction Chart - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/09/2022) (3) |
| Nov 9, 2022 | 44 | STIPULATION and [Proposed] Order Regarding Claim Construction - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/09/2022) (4) |
| Nov 9, 2022 | 43 | CLAIM Construction Chart by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # 1 Ex. A - '833 Patent, # 2 Ex. B - '893 Patent)(Murray, Travis) (Entered: 11/09/2022) (Main Document) (16) |
| Nov 7, 2022 | 42 | STIPULATION TO EXTEND TIME to submit the Joint Claim Construction Chart to November 9, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 11/07/2022) (2) |
| Nov 7, 2022 | 41 | SO ORDERED, re 40 Joint STIPULATION TO EXTEND TIME OF SUBSTANTIAL COMPLETION OF DOCUMENT PRODUCTION to 01/06/2023, filed by Hikma Pharmaceuticals USA Inc. Signed by Judge Colm F. Connolly on 11/7/2022. (kmd) (Entered: 11/07/2022) (3) |
| Nov 7, 2022 | 40 | Joint STIPULATION TO EXTEND TIME OF SUBSTANTIAL COMPLETION OF DOCUMENT PRODUCTION to 01/06/2023 - filed by Hikma Pharmaceuticals USA Inc.. (Lennon, James) (Entered: 11/07/2022) (3) |
| Nov 2, 2022 | 39 | NOTICE OF SERVICE of Plaintiffs' Proposed Claim Terms for Construction filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 11/02/2022) (3) |
| Nov 2, 2022 | 38 | NOTICE OF SERVICE of Defendant Hikma Pharmaceuticals USA Inc.'s List of Proposed Claim Terms for Construction filed by Hikma Pharmaceuticals USA Inc..(Lennon, James) (Entered: 11/02/2022) (2) |
| Oct 27, 2022 | 37 | STIPULATION TO EXTEND TIME to submit the Joint Claim Construction Chart to November 7, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/27/2022) (2) |
| Oct 24, 2022 | 36 | NOTICE OF SERVICE of Novo Nordisk's Preliminary Identification of Claim Terms and Phrases for Construction - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 10/24/2022) (3) |
| Oct 24, 2022 | 35 | NOTICE OF SERVICE of Defendant Hikma Pharmaceuticals USA Inc.'s List of Proposed Claim Terms for Construction filed by Hikma Pharmaceuticals USA Inc..(Lennon, James) (Entered: 10/24/2022) (2) |
| Oct 6, 2022 | 34 | REDACTED VERSION of Notice of Subpoena filed on 9-28-2022 - by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 10/06/2022) (30) |
| Sep 30, 2022 | 33 | NOTICE OF SERVICE of Novo Nordisk's Initial Responses to Defendants' Invalidity Contentions Regarding U.S. Patent Nos. 8,114,833 and 9,265,893 filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/30/2022) (3) |
| Sep 28, 2022 | 32 | [SEALED] NOTICE of Subpoena - by Novo Nordisk A/S, Novo Nordisk Inc. (Murray, Travis) (Entered: 09/28/2022) (0) |
| Sep 23, 2022 | 31 | NOTICE OF SERVICE of Plaintiffs' Initial Infringement Contentions - filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) (Entered: 09/23/2022) (3) |
| Sep 15, 2022 | 30 | MOTION for Pro Hac Vice Appearance of Attorney Olivia L. Wheeling - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Murray, Travis) (Entered: 09/15/2022) (4) |
| Aug 29, 2022 | 29 | NOTICE of of Service of (1) Defendant Hikma Pharmaceuticals USA Inc.s Objections and Responses to Plaintiffs Second Set of Requests for the Production of Documents and Things (Nos. 7-84); and (2) Defendant Hikma Pharmaceuticals USA Inc.s Objections and Responses to Plaintiffs First Set of Interrogatories (Nos. 1-14) by Hikma Pharmaceuticals USA Inc. (Lennon, James) (Entered: 08/29/2022) (2) |
| Aug 8, 2022 | 28 | NOTICE OF SERVICE of Defendant Hikma Pharmaceuticals USA Inc.'s Initial Non-Infringement Contentions filed by Hikma Pharmaceuticals USA Inc..(Lennon, James) (Entered: 08/08/2022) (2) |
| Jul 22, 2022 | 27 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' First Set of Interrogatories (Nos. 1-14); and (2) Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 7-84) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Murray, Travis) |
| Jul 18, 2022 | 26 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendant Hikma Pharmaceuticals USA Inc.'s Objections and Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-6) filed by Hikma Pharmaceuticals USA Inc..(Lennon, James) |
| Jul 1, 2022 | 25 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' Preliminary Disclosure of Asserted Claims filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jun 17, 2022 | 24 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-6) filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| Jun 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [23] Stipulation Regarding the Discovery of Electronically Stored Information, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 6/3/2022. (kmd) Modified on 6/3/2022 (kmd). |
| Jun 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [22] Proposed Protective Order, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 6/3/2022. (kmd) |
| Jun 2, 2022 | 23 | Stipulation (14) Docket Text: STIPULATION and Proposed Order Regarding the Discovery of Electronically Stored Information by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| Jun 2, 2022 | 22 | Proposed Order (30) Docket Text: PROPOSED ORDER -- Protective Order -- by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| May 25, 2022 | 21 | SO ORDERED (2) Docket Text: SO ORDERED, re [20] STIPULATION TO EXTEND TIME to submit a proposed order for the discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to June 2, 2022, filed by Novo Nordisk A/S, Novo Nordisk Inc. Signed by Judge Colm F. Connolly on 5/25/2022. (kmd) |
| May 25, 2022 | 20 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed order for the discovery of electronically-stored information ("ESI Order") and a proposed Protective Order to June 2, 2022 - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Egan, Brian) |
| May 19, 2022 | 19 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Disclosures Under Paragraph 3 of the District of Delaware Default Standard; and (2) Plaintiffs' Disclosures Pursuant to Rule 26(a)(1) of the Federal Rules of Civil Procedure filed by Novo Nordisk A/S, Novo Nordisk Inc..(Egan, Brian) |
| May 19, 2022 | 18 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendant Hikma Pharmaceuticals USA Inc.'s Rule 26(a)(1) Initial Disclosures; and (2) Defendant Hikma Pharmaceuticals USA Inc.'s Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by Hikma Pharmaceuticals USA Inc..(Lennon, James) |
| May 5, 2022 | 17 | Scheduling Order (30) Docket Text: SCHEDULING ORDER: Joinder of Parties due by 2/10/2023. Amended Pleadings due by 2/10/2023. Fact Discovery completed by 3/10/2023. Expert Discovery due by 8/4/2023. Joint Claim Construction Brief due by 1/9/2023. A Markman Hearing is set for 2/7/2023 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Proposed Pretrial Order due by 10/31/2023. A Final Pretrial Conference is set for 11/21/2023 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly. A Bench Trial is set for 12/4/2023 at 08:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 5/5/2022. (nmf) |
| May 4, 2022 | 16 | Letter to The Honorable Colm F. Connolly (1) |
| May 4, 2022 | 16 | Main Document (34) Docket Text: PROPOSED ORDER -- [Proposed] Scheduling Order -- by Novo Nordisk A/S, Novo Nordisk Inc.. (Attachments: # (1) Letter to The Honorable Colm F. Connolly)(Egan, Brian) |
| May 4, 2022 | N/A | Remark (0) Docket Text: The 5/6/2022 Scheduling Conference is canceled per D.I. [16]. (nmf) |
| Mar 30, 2022 | 15 | Order Setting Scheduling Conference (1) Docket Text: Order Setting Telephonic Scheduling Conference: A Scheduling Conference is set for 5/6/2022 at 08:30 AM Telephonically before Judge Colm F. Connolly. If the parties have no disputes about the scheduling order, the Court will not require the parties to appear at a conference. Signed by Judge Colm F. Connolly on 3/30/2022. (nmf) |
| Mar 4, 2022 | 14 | Letter (1) Docket Text: Letter to The Honorable Colm F. Connolly from Brian P. Egan regarding coordinated discovery and Markman - re (13 in 1:21-cv-01783-CFC, 13 in 1:21-cv-01783-CFC, 10 in 1:21-cv-01782-CFC, 10 in 1:21-cv-01782-CFC) Order,, Set Deadlines,. (Egan, Brian) |
| Feb 17, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sharon Lin for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (apk) |
| Feb 4, 2022 | 13 | Order (2) Docket Text: ORDER: IT IS ORDERED that, on or before March 4, 2022, counsel for plaintiffs shall inform the court as to whether the need for coordinated discovery and/or Markman proceedings is anticipated as to the above cases and, if so, when a joint scheduling conference might most efficiently be conducted.ORDER, Setting Deadlines: ( Notice of Compliance deadline set for 3/4/2022.) Signed by Judge Colm F. Connolly on 2/4/2022. Associated Cases: 1:21-cv-01782-CFC, 1:21-cv-01783-CFC(nmf) |
| Feb 3, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [12] MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran and Erica R. Sutter, filed by Novo Nordisk A/S, Novo Nordisk Inc. Ordered by Judge Colm F. Connolly on 2/3/2022. (kmd) |
| Feb 3, 2022 | 12 | Motion for Leave to Appear Pro Hac Vice (8) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Jeffrey J. Oelke, Ryan P. Johnson, Robert E. Counihan, Laura T. Moran and Erica R. Sutter - filed by Novo Nordisk A/S, Novo Nordisk Inc.. (Blumenfeld, Jack) |
| Feb 2, 2022 | 11 | Answer to Counterclaim (13) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim -- Answer to Counterclaims -- by Novo Nordisk A/S, Novo Nordisk Inc..(Blumenfeld, Jack) |
| Jan 14, 2022 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Charles B. Klein for Hikma Pharmaceuticals USA Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (twk) |
| Jan 13, 2022 | 10 | Motion for Leave to Appear Pro Hac Vice (3) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Sharon Lin - filed by Hikma Pharmaceuticals USA Inc.. (Lennon, James) |
| Jan 13, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney Charles B. Klein and Sharon Lin, filed by Hikma Pharmaceuticals USA Inc. Ordered by Judge Colm F. Connolly on 1/13/2022. (kmd) |
| Jan 12, 2022 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Hikma Pharmaceuticals, PLC for Hikma Pharmaceuticals USA Inc. filed by Hikma Pharmaceuticals USA Inc.. (Lennon, James) |
| Jan 12, 2022 | 8 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, , COUNTERCLAIM against Novo Nordisk A/S, Novo Nordisk Inc. by Hikma Pharmaceuticals USA Inc..(Lennon, James) |
| Jan 12, 2022 | N/A | Remark (0) Docket Text: Remark: DI 9 re Disclosure Statement removed per Request of Counsel and will be refiled. (twk) |
| Dec 29, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:21-cv-01782-CFC, 1:21-cv-01783-CFC (rjb) |
| Dec 22, 2021 | 7 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Novo Nordisk Inc., Novo Nordisk A/S. Hikma Pharmaceuticals USA Inc. served on 12/22/2021, answer due 1/12/2022. (Blumenfeld, Jack) |
| Dec 21, 2021 | 1 | Complaint* (1) |
| Dec 21, 2021 | 6 | Summons Issued (2) Docket Text: Summons Issued with Magistrate Consent Notice attached as to Hikma Pharmaceuticals USA Inc. on 12/22/2021. (mal) |
| Dec 21, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novo A/S for Novo Nordisk A/S; Corporate Parent Novo Nordisk US Holdings, Inc. for Novo Nordisk Inc.; and Novo Nordisk US Holdings Inc. is a privately held corporation wholly owned by Novo Nordisk A/S. - filed by Novo Nordisk A/S and Novo Nordisk Inc.. (mal) |
| Dec 21, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,579,869 B2 ;7,762,994 B2 ;8,114,833 B2 ;9,265,893 B2. (mal) |
| Dec 21, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 11/12/2021. Date of Expiration of Patent: see attached.Thirty Month Stay Deadline: 5/12/2024. (mal) |
| Dec 21, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mal) |
| Dec 21, 2021 | 1 | Civil Cover Sheet (1) |
| Dec 21, 2021 | 1 | Exhibit A-D (62) |
| Dec 21, 2021 | 1 | Main Document (9) Docket Text: COMPLAINT filed against Hikma Pharmaceuticals USA Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3768392.) - filed by Novo Nordisk Inc., Novo Nordisk A/S. (Attachments: # (1) Exhibit A-D, # (2) Civil Cover Sheet)(mal) |
